Literature DB >> 31381996

Toxoplasmosis as an Early Complication of Allogeneic Hematopoietic Cell Transplantation.

Christine Robin1, Mathieu Leclerc2, Cécile Angebault3, Rabah Redjoul4, Florence Beckerich4, Ludovic Cabanne4, Francoise Foulet5, Cécile Pautas4, Andréa Toma4, Sébastien Maury2, Francoise Botterel6, Catherine Cordonnier2.   

Abstract

Among 419 consecutive allogeneic hematopoietic cell transplant recipients, we observed 17 (4.0%) cases of toxoplasmosis at a median time of day 45 (range, 6 to 322) after transplant. Seven of these 17 cases occurred before day 30 after transplant. Because of the lack of PCR screening and trimethoprim-sulfamethoxazole prophylaxis before engraftment, the diagnosis of toxoplasmosis was late, and 5 of these 7 patients died. Analyzing these cases, early Toxoplasma blood PCR screening, starting from transplant, is crucial.
Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic hematopoietic cell transplantation; PCR; Toxoplasma gondii; Toxoplasmosis; Trimethoprim-sulfamethoxazole

Year:  2019        PMID: 31381996     DOI: 10.1016/j.bbmt.2019.07.035

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  1 in total

1.  Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.

Authors:  Ruth O Adekunle; Amy Sherman; Jennifer O Spicer; Julia A Messina; Julie M Steinbrink; Mary Elizabeth Sexton; George Marshall Lyon; Aneesh K Mehta; Varun K Phadke; Michael H Woodworth
Journal:  Transpl Infect Dis       Date:  2021-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.